Apollo Hospitals Enterprise Ltd. Sees Robust Trading Activity Amid Sector Gains

Trading Activity and Price Performance

On 11 Feb 2026, Apollo Hospitals (symbol: APOLLOHOSP) recorded a total traded volume of 6,41,897 shares, translating into a substantial traded value of ₹48,490.76 lakhs. The stock opened at ₹7,405, marking a gap-up of 2.58% from the previous close of ₹7,219. It further rallied to touch an intraday high of ₹7,640, representing a 5.83% gain from the open and a 5.04% increase over the previous close. The last traded price (LTP) stood at ₹7,600 as of 09:44:46 IST, underscoring sustained buying momentum in early trading hours.

Notably, Apollo Hospitals has been on a consistent upward trajectory, gaining for seven consecutive sessions and delivering a cumulative return of 9.45% during this period. This steady appreciation highlights growing investor confidence in the company’s fundamentals and growth prospects.

Sectoral Context and Comparative Performance

The Hospital & Healthcare Services sector advanced by 3.08% on the same day, with Apollo Hospitals outperforming the sector by 2.47 percentage points. In contrast, the benchmark Sensex remained largely flat, registering a marginal decline of 0.01%. This divergence emphasises the stock’s relative strength amid mixed market conditions.

From a technical standpoint, Apollo Hospitals is trading above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a robust bullish trend. Such positioning often attracts institutional investors seeking momentum plays backed by strong technicals.

Institutional Interest and Liquidity Considerations

Despite the strong price gains, investor participation measured by delivery volume has shown signs of moderation. On 10 Feb 2026, delivery volume fell by 43.86% to 1.35 lakh shares compared to the five-day average, suggesting some profit-booking or cautious stance among long-term holders. However, the stock remains sufficiently liquid, with the average traded value supporting trade sizes up to ₹5.36 crores comfortably, facilitating large order flows without significant price impact.

Apollo Hospitals’ market capitalisation stands at ₹1,03,813 crores, categorising it as a large-cap stock with a Market Cap Grade of 1. This scale typically attracts institutional investors, including mutual funds and foreign portfolio investors, who seek stable yet growth-oriented healthcare plays.

Mojo Score and Rating Revision

Apollo Hospitals currently holds a Mojo Score of 55.0, placing it in the 'Hold' category. This represents a downgrade from its previous 'Buy' rating, which was revised on 09 Jan 2026. The downgrade reflects a more cautious outlook based on recent financial metrics and market dynamics, although the stock’s strong price action suggests that investors are still optimistic about near-term prospects.

The Mojo Grade downgrade signals that while the company maintains solid fundamentals, certain valuation or growth concerns may have prompted a reassessment. Investors should weigh this alongside the stock’s technical strength and sectoral tailwinds before making allocation decisions.

Outlook and Strategic Considerations

Given Apollo Hospitals’ leadership position in the hospital industry and its large-cap status, it remains a key stock to watch within the healthcare sector. The company’s ability to sustain its upward momentum will depend on continued operational performance, sector growth, and broader market conditions.

Investors should also monitor institutional activity closely, as large order flows and liquidity levels suggest that the stock is well-positioned for sizeable trades. However, the recent dip in delivery volumes may indicate some short-term profit-taking or rotation into other healthcare names.

Conclusion

Apollo Hospitals Enterprise Ltd. continues to command significant attention in the equity markets, driven by high-value trading volumes and a strong price rally that outpaces its sector and the broader market. While the recent Mojo Grade downgrade introduces a note of caution, the stock’s technical strength and liquidity profile make it a compelling candidate for investors seeking exposure to the healthcare sector’s growth story.

Market participants should remain vigilant of evolving institutional interest and delivery volume trends, which may provide early signals of shifts in investor sentiment. Overall, Apollo Hospitals remains a pivotal large-cap stock with a nuanced outlook that balances solid fundamentals against valuation and market dynamics.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →